Thank you for subscribing!
Next Investors Apr 17, 2024
Today, our biotech Investment Neurotech International (ASX: NTI) announced that BOTH of its clinical trials for Autism Spectrum Disorder (ASD) and Rett Syndrome had met the trials’ primary endpoints.
Next Investors Mar 08, 2024
Yesterday, our biotech investment Emyria (ASX:EMD) was up 37% on no news.
Finfeed Archived Jun 15, 2020
eSense-Lab Limited (ASX: ESE) has entered a JV with ANC Enterprises to provide specific terpenes uniquely developed for a range of skin care, hair care and hand sanitiser products. ANC will formulate and manufacture the resulting products containing ESE’s proprietary terpene mixes.
Finfeed Archived May 11, 2020
There has been continual strong news flow from the Genetic Signature Ltd (ASX: GSS), as it received CE-IVD registration for its SARS-CoV-2 Detection Kit, as well as notification from the Therapeutic Goods Administration (TGA) that its EasyScreenTM SARS-CoV-2 Detection Kit has been approved to be listed on the ARTG in Australia.
Get expert stock analysis direct in your inbox
Finfeed Archived Apr 17, 2020
PharmAust Limited (ASX: PAA) has entered into a Materials Transfer Agreement with the Walter and Eliza Hall Institute of Medical Research (WEHI) to test the effects of monepantel (MPL) on COVID-19 infections.
Join Our Mailing List
